Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Clin Psychiatry. 2004 Apr-Jun;16(2):87-100.

Pharmacotherapy of depression in pregnancy.

Author information

1
Department of Psychiatry, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. ashwin.patkar@jefferson.edu

Abstract

About 20% of pregnant women experience clinical depression. Inadequate treatment of depression has been associated with adverse outcomes in the mother as well as the newborn. Clinicians are often uncertain about pharmacological interventions to treat depressed pregnant women due to concerns regarding fetal exposure to medications. Moreover newer antidepressants with different pharmacological profiles and little data on fetal risk continue to be introduced at a brisk pace. Accumulating data from pharmaceutical registries, cohort studies, toxicology centers, some prospective studies, and case series have permitted certain guidelines for antidepressant use during pregnancy. We review the safety profiles of commonly used antidepressants, discuss clinical decision making based on risk-benefit considerations and make recommendations for pharmacological treatment of depressed women during pregnancy.

PMID:
15328902
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center